These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17406212)

  • 1. Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform.
    Edwards BS; Young SM; Oprea TI; Bologa CG; Prossnitz ER; Sklar LA
    Nat Protoc; 2006; 1(1):59-66. PubMed ID: 17406212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands.
    Young SM; Bologa C; Prossnitz ER; Oprea TI; Sklar LA; Edwards BS
    J Biomol Screen; 2005 Jun; 10(4):374-82. PubMed ID: 15964939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists.
    Edwards BS; Bologa C; Young SM; Balakin KV; Prossnitz ER; Savchuck NP; Sklar LA; Oprea TI
    Mol Pharmacol; 2005 Nov; 68(5):1301-10. PubMed ID: 16118363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput flow cytometry: validation in microvolume bioassays.
    Ramirez S; Aiken CT; Andrzejewski B; Sklar LA; Edwards BS
    Cytometry A; 2003 May; 53(1):55-65. PubMed ID: 12701132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.
    Young SM; Bologa CM; Fara D; Bryant BK; Strouse JJ; Arterburn JB; Ye RD; Oprea TI; Prossnitz ER; Sklar LA; Edwards BS
    Cytometry A; 2009 Mar; 75(3):253-63. PubMed ID: 18785269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry for high-throughput, high-content screening.
    Edwards BS; Oprea T; Prossnitz ER; Sklar LA
    Curr Opin Chem Biol; 2004 Aug; 8(4):392-8. PubMed ID: 15288249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput flow cytometry.
    Kuckuck FW; Edwards BS; Sklar LA
    Cytometry; 2001 May; 44(1):83-90. PubMed ID: 11309812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-content screening: flow cytometry analysis.
    Edwards BS; Young SM; Ivnitsky-Steele I; Ye RD; Prossnitz ER; Sklar LA
    Methods Mol Biol; 2009; 486():151-65. PubMed ID: 19347622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-receptor-G-protein molecular assemblies on beads for mechanistic studies and screening by flow cytometry.
    Simons PC; Shi M; Foutz T; Cimino DF; Lewis J; Buranda T; Lim WK; Neubig RR; McIntire WE; Garrison J; Prossnitz E; Sklar LA
    Mol Pharmacol; 2003 Nov; 64(5):1227-38. PubMed ID: 14573773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligands.
    Kinzer-Ursem TL; Sutton KL; Waller A; Omann GM; Linderman JJ
    Cell Signal; 2006 Oct; 18(10):1732-47. PubMed ID: 16530386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTPS flow cytometry: a novel platform for automated high throughput drug discovery and characterization.
    Edwards BS; Kuckuck FW; Prossnitz ER; Ransom JT; Sklar LA
    J Biomol Screen; 2001 Apr; 6(2):83-90. PubMed ID: 11689102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.
    Strouse JJ; Young SM; Mitchell HD; Ye RD; Prossnitz ER; Sklar LA; Edwards BS
    Cytometry A; 2009 Mar; 75(3):264-70. PubMed ID: 19006074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid mix flow cytometer with subsecond kinetic resolution.
    Nolan JP; Posner RG; Martin JC; Habbersett R; Sklar LA
    Cytometry; 1995 Nov; 21(3):223-9. PubMed ID: 8582244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput microfluidic mixing and multiparametric cell sorting for bioactive compound screening.
    Young SM; Curry MS; Ransom JT; Ballesteros JA; Prossnitz ER; Sklar LA; Edwards BS
    J Biomol Screen; 2004 Mar; 9(2):103-11. PubMed ID: 15006133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques: GPCR assembly, pharmacology and screening by flow cytometry.
    Waller A; Simons PC; Biggs SM; Edwards BS; Prossnitz ER; Sklar LA
    Trends Pharmacol Sci; 2004 Dec; 25(12):663-9. PubMed ID: 15530645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.
    Devosse T; Guillabert A; D'Haene N; Berton A; De Nadai P; Noel S; Brait M; Franssen JD; Sozzani S; Salmon I; Parmentier M
    J Immunol; 2009 Apr; 182(8):4974-84. PubMed ID: 19342677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional role of formyl peptide receptor in human bone marrow-derived mesenchymal stem cells.
    Kim MK; Min do S; Park YJ; Kim JH; Ryu SH; Bae YS
    FEBS Lett; 2007 May; 581(9):1917-22. PubMed ID: 17442310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsphere-based molecular cytometry.
    Iannone MA
    Clin Lab Med; 2001 Dec; 21(4):731-42. PubMed ID: 11770284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.